Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Inventory (2020 - 2025)

Historic Inventory for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $18.1 million.

  • NeuroPace's Inventory rose 5007.45% to $18.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.1 million, marking a year-over-year increase of 5007.45%. This contributed to the annual value of $13.4 million for FY2024, which is 1932.41% up from last year.
  • As of Q3 2025, NeuroPace's Inventory stood at $18.1 million, which was up 5007.45% from $16.3 million recorded in Q2 2025.
  • In the past 5 years, NeuroPace's Inventory registered a high of $18.1 million during Q3 2025, and its lowest value of $7.0 million during Q2 2021.
  • In the last 5 years, NeuroPace's Inventory had a median value of $10.0 million in 2023 and averaged $10.6 million.
  • Its Inventory has fluctuated over the past 5 years, first soared by 619.53% in 2024, then surged by 5007.45% in 2025.
  • Over the past 5 years, NeuroPace's Inventory (Quarter) stood at $7.8 million in 2021, then grew by 24.16% to $9.7 million in 2022, then rose by 15.47% to $11.2 million in 2023, then grew by 19.32% to $13.4 million in 2024, then surged by 35.53% to $18.1 million in 2025.
  • Its Inventory was $18.1 million in Q3 2025, compared to $16.3 million in Q2 2025 and $13.6 million in Q1 2025.